Showing results 1 to 2 of 2
| Issue Date | Title | Journal Title |
|---|---|---|
| 2025 | Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC | ONCOLOGIST |
| 2025 | Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer | NEW ENGLAND JOURNAL OF MEDICINE |